Matches in Nanopublications for { ?s ?p "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP233333.RAXarlepr0ZKxwSWcw9xtkd10TNVmxNRsQmD_cAudXoFs130_assertion description "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233333.RAXarlepr0ZKxwSWcw9xtkd10TNVmxNRsQmD_cAudXoFs130_provenance.
- assertion description "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion description "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.
- assertion description "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.